Liver fibrosis is the liver’s own repair process going wrong. When injury keeps happening, the liver lays down scar tissue faster than it can clear it. The injury can come from several directions, most commonly a fatty liver tied to weight and blood sugar, alcohol, or long-lasting hepatitis B or C. Unlike a scar on the skin, liver scarring is not necessarily permanent, and it often shrinks once the cause is dealt with.1PubMed. Molecular and cellular mechanisms of liver fibrosis and its regression Treatment therefore centres less on the scar itself than on stopping whatever is causing it.
How Ongoing Injury Turns Into Scar Tissue
The liver contains resting cells whose normal job is storing vitamin A.2Nature Reviews Gastroenterology & Hepatology. Hepatic stellate cells and liver fibrosis When the liver is injured over and over, these cells wake up, multiply and start producing scar tissue.3Nature Reviews Gastroenterology & Hepatology. Hepatic stellate cells and liver fibrosis Chemical alarm signals released by damaged tissue push them to grow and make collagen, the main protein in scars.4PubMed Central. Therapeutic targeting of the PDGF and TGF-β-signaling pathways in hepatic stellate cells by PTK787/ZK22258 The woken cells can also tighten and squeeze the liver’s blood vessels, raising pressure in the vein that feeds the liver.5PubMed. Hepatic stellate cells and liver fibrosis
Inflammation keeps the cycle going. The liver’s resident immune cells sense damage first and sound the alarm.6PubMed. Macrophage heterogeneity in liver injury and fibrosis That alarm draws in more immune cells from the blood, which keep inflammation going and further switch on scar-making cells.7PubMed. Targeting hepatic macrophages to treat liver diseases As long as the injury continues, inflammation and scarring feed each other. Over years, scar can replace enough normal tissue to cause cirrhosis, the advanced stage where the liver’s structure is badly distorted.8PubMed Central. Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
The process is slow, usually unfolding over years or decades, so the injury that started it may be long past or still quietly ongoing. The liver has no pain-sensing nerves inside its tissue, so scarring itself does not hurt, and the liver keeps working well even with substantial scar. Many people learn of fibrosis only from a routine blood test or scan, and feeling well does not mean the scarring is mild.
Fatty Liver Disease, the Most Common Cause
Doctors now call fatty liver disease MASLD, metabolic dysfunction-associated steatotic liver disease, meaning fat in the liver linked to weight, blood sugar or cholesterol problems. It is driven by several linked problems, including how the body handles fat, insulin resistance and chronic inflammation.9PubMed Central. Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances Only a subset of people with fatty liver go on to advanced scarring.10PubMed Central. Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances
Fat alone is not the whole problem. Simple fatty liver, where fat sits in the liver without much inflammation, often stays stable and causes little scarring. Trouble starts when fat-laden liver cells become stressed and inflamed, which triggers the scar-making response. That explains why two people with equally fatty livers can have very different amounts of scarring.
The gut plays a part too. People with fatty liver tend to have a leakier gut lining than healthy people, so bacterial products can pass from the gut into the vein that drains to the liver.11PubMed Central. Interactions Between the Intestinal Microbiome and Liver Diseases These products trigger inflammation in the liver that pushes simple fatty liver toward the inflamed, scarring form.12PubMed Central. Interactions Between the Intestinal Microbiome and Liver Diseases
Type 2 diabetes, obesity (especially around the waist) and high triglycerides raise the risk. You can also have fatty liver without being heavy if your blood sugar is high. Your report may say MASH, the inflamed form that is more likely to scar.
The condition was long called NAFLD, non-alcoholic fatty liver disease, and older reports and websites still use NAFLD and NASH. They describe essentially the same condition, so the old names on your records are not a different diagnosis.
Alcohol, Hepatitis and Other Causes
Breaking down alcohol creates harmful oxygen molecules that directly switch on the liver’s scar-making cells.13PubMed Central. Oxidative Stress and Alcohol-Related Hepatitis: A Role for Future Therapies Those cells and the liver’s main scarring signal then amplify each other, creating a self-sustaining cycle.14PubMed Central. Oxidative Stress and Alcohol-Related Hepatitis: A Role for Future Therapies The risk of alcohol-related scarring rises with the amount drunk and the number of years of drinking, and it varies from person to person. Women tend to develop alcohol-related liver damage at lower levels of intake than men.
Hepatitis B and C scar the liver mainly through years of inflammation and repeated attempts at repair.15PubMed Central. Prediction of fibrosis progression in chronic viral hepatitis Parts of the hepatitis B virus can also switch on scar-making cells directly.16PubMed Central. Prediction of fibrosis progression in chronic viral hepatitis Hepatitis B can progress through scarring to cirrhosis or liver cancer.17PubMed Central. Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models
Less common causes exist as well. In hereditary hemochromatosis, the gut absorbs too much iron, which builds up in the liver and damages it until scarring follows.18PubMed. Iron homeostasis, hepatocellular injury, and fibrogenesis in hemochromatosis: the role of inflammation in a noninflammatory liver disease Some medicines cause lasting liver injury, and up to 18% of drug-related liver injury cases become long-term.19Ovid. Chronic liver injury induced by drugs: a systematic review Common antibiotics such as amoxicillin-clavulanate and trimethoprim-sulfamethoxazole are among the most likely to cause long-lasting injury.20Ovid. Chronic liver injury induced by drugs: a systematic review Rarely, children are born with congenital hepatic fibrosis, an inherited condition in which bile ducts and liver blood vessels form improperly.21Children’s Hospital Colorado. Pediatric Congenital Hepatic Fibrosis
Many people have more than one cause, such as fatty liver plus drinking, and combined causes generally speed scarring. So doctors usually test for several causes at once. Blood tests check for hepatitis B and C antibodies or virus, and iron studies screen for hemochromatosis. They will also review your alcohol use and every medicine and supplement you take.
Can Liver Fibrosis Be Reversed
Fibrosis can regress in people when the cause is removed.22PubMed. Molecular and cellular mechanisms of liver fibrosis and its regression Scar-making cells die off or switch back to their resting state, and roughly half return to rest rather than dying.23PubMed Central. Reversibility of Liver Fibrosis Immune cells change role and release enzymes that dissolve existing scar.24PubMed Central. Reversibility of Liver Fibrosis
Recovery takes months to years, not weeks. Early stages are the most likely to reverse fully. Cirrhosis can improve, but some structural damage may remain, and follow-up is needed even after improvement.
How fast and how far the liver recovers depends on the cause. When the cause can be completely removed, as with a cured hepatitis C infection, the liver has the clearest chance to remodel. When it can only be reduced, such as with partial weight loss, the injury continues at a lower level and improvement may be smaller. If alcohol or another injury restarts, the scarring resumes, so recovery lasts only as long as the injury stays away.
How Doctors Measure the Scarring
Fibrosis is graded on a scale from F0, no scarring, to F4, cirrhosis. A FibroScan measures liver stiffness with a painless probe on the skin, reported in kilopascals (kPa). Blood-based scores such as the ELF test and FibroTest estimate scarring from substances in the blood.25PubMed Central. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis These tests are good at picking out cirrhosis and less reliable at separating the middle fibrosis stages.26PubMed Central. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
For the stiffness scan, you lie on your back while the probe is placed on the right side of your ribs. It takes about 10 minutes, and you are usually asked to fast first. Inflammation, recent meals or heavy drinking can falsely raise the reading.
A higher kPa number means a stiffer, more scarred liver. Cutoffs differ by cause, so ask your doctor which fibrosis stage your number suggests. Your report may also list FIB-4, a simple score from routine blood tests. The stiffness scan rarely misses scarring but can overcall it.27PubMed. Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint A liver biopsy remains the most accurate test and is used when results are unclear.28PubMed. Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint
If two tests disagree, that is a common reason to repeat one or consider a biopsy. A single reading is only a snapshot, so trends over repeat tests say more than one number.
Treating the Cause
Modern antiviral pills cure most hepatitis C infections in 8 to 12 weeks. After treatment, scarring improved in about 57% of people and worsened in about 7%.29PubMed Central. Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents About 28% moved from advanced scarring down to moderate or less.30PubMed Central. Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents
Weight loss is the main treatment for fatty liver, and losing around 7 to 10% of body weight is commonly advised to improve inflammation and scarring. Resmetirom (Rezdiffra) is a daily pill approved in the US for inflamed fatty liver with moderate to advanced scarring. In a large trial, about 1 in 4 people on it improved by at least one scar stage, against about 1 in 7 on a dummy pill.31PubMed. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis In people with early cirrhosis taking it for up to 2 years, about 35% showed stiffness results moving back from cirrhosis range.32P4 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis. P4 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis
For alcohol-related scarring, stopping drinking completely is the treatment. Hepatitis B is controlled with long-term antiviral pills, and hemochromatosis with regular blood removal. If a medicine is the cause, stopping it under a doctor’s guidance removes the injury.
Some everyday steps protect a scarred liver whatever the cause. Cut out or sharply reduce alcohol, even if it was not the main cause. Ask before taking supplements or herbal remedies. Get vaccinated against hepatitis A and B if you are not immune, and manage diabetes and cholesterol, which drive fatty liver.
It helps to ask your doctor whether your stage and cause qualify you for resmetirom, and how progress will be checked, often with repeat stiffness scans. You can also ask whether weight-loss medicines suit you.
What Happens if Fibrosis Progresses
Liver cancer risk climbs with stage. In people with hepatitis C, 5-year liver cancer risk was about 1% with mild to severe fibrosis but about 13% with cirrhosis.33PubMed Central. Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort Even after hepatitis C is cured, people with cirrhosis develop liver cancer at about 3 per 100 each year.34PubMed Central. Fibrosis-stage Specific Incidence of Hepatocellular Cancer after Hepatitis C Cure with Direct-Acting Antivirals: A Systematic Review & Meta-analysis In hepatitis B, liver stiffness above 8 kPa was linked to around 3 to 7 times higher cancer risk, rising with the reading.35PubMed. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) People with cirrhosis therefore need cancer screening even after the cause is treated.
Screening usually means an ultrasound every 6 months, often with a blood test. It aims to catch tumours early, when they are treatable, and it continues even after fibrosis improves.
Advanced scarring also raises pressure in the liver’s main vein, which can cause bleeding from swollen veins and fluid buildup in the belly.36PubMed. Long-term sequelae of drug-induced liver injury Untreated, scarring can progress to liver failure.37PubMed Central. Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
Cirrhosis can be compensated, meaning the liver still copes and there are no symptoms, or decompensated, meaning complications have appeared. Many people live for years in the compensated phase, which is why monitoring is aimed at catching problems before symptoms. Moving from one phase to the other is often triggered by ongoing injury, infection or bleeding. Some signs need prompt attention: yellowing of the skin or eyes, swelling of the belly or legs, vomiting blood or passing black, tarry stools, and confusion or unusual sleepiness.
New Treatments on the Horizon
Around 120 drugs with anti-scarring effects have been identified, some in late-stage trials.38PubMed Central. New Drugs for Hepatic Fibrosis Most have disappointed in human trials, partly because animal models don’t fully capture human liver disease.39PubMed Central. New Drugs for Hepatic Fibrosis Stem cell infusions can calm scar-making cells and help dissolve scar, but remain in clinical trials.40PubMed Central. Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Joining a clinical trial can give early access to new treatments. Ask your liver specialist or search a public trial registry, and be wary of clinics selling unproven stem cell treatments for cash.